Caliway Biopharmaceuticals Co., Ltd. Stock
Stocks
6919
TW0006919004
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Taiwan S.E.
2026-09-18
|
5-day change | 1st Jan Change | ||
| 85.80 TWD | +3.50% |
|
+7.92% | -44.65% |
| Market Cap | 133B 4.19B 3.66B 3.45B 3.13B 5.87B 402B 5.9B 41.35B 15.96B 205B 15.75B 15.4B 658B | P/E 2026 * |
36.4x | P/E 2027 * | 16x |
|---|---|---|---|---|---|
| Enterprise Value | 125B 3.93B 3.43B 3.23B 2.94B 5.5B 377B 5.53B 38.75B 14.95B 192B 14.76B 14.43B 617B | EV / Sales 2026 * |
20.7x | EV / Sales 2027 * | 10.4x |
| Free-Float |
-
| Yield 2026 * |
0.83% | Yield 2027 * | 1.88% |
| 1 day | +3.50% | ||
| 1 week | +7.92% | ||
| Current month | -9.49% | ||
| 1 month | -17.89% | ||
| 3 months | -21.28% | ||
| 6 months | -26.03% | ||
| Current year | -44.65% |
| 1 week | 78.9 |  | 86 |
| 1 month | 77.3 | | 118.5 |
| Current year | 75.1 | | 181 |
| 1 year | 75.1 | | 203 |
| 3 years | 18.15 | | 277 |
| 5 years | 5.55 | | 277 |
| 10 years | 5.55 | | 277 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yu Fang Ling
CEO | Chief Executive Officer | - | 2013-05-01 |
Hui Min Chang
DFI | Director of Finance/CFO | - | 2026-02-23 |
Laura Chung
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Kuei Hui Hsu
CHM | Chairman | - | 2020-06-28 |
Kao-Jung Chang
BRD | Director/Board Member | - | 2020-06-28 |
Yu Fang Ling
BRD | Director/Board Member | - | 2013-05-01 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.50% | +7.92% | -56.22% | +247.02% | 4.19B | |
| +0.04% | +3.34% | +51.12% | +101.82% | 1,028B | |
| -0.09% | +1.66% | +55.02% | +66.18% | 651B | |
| -0.02% | +2.66% | +18.91% | +71.47% | 466B | |
| -1.22% | +3.66% | +36.44% | +38.32% | 346B | |
| -0.79% | +2.73% | +19.03% | +25.08% | 266B | |
| +0.58% | +6.76% | +11.13% | +16.52% | 259B | |
| +1.55% | +2.20% | +39.81% | +46.55% | 208B | |
| +0.79% | +1.84% | -28.27% | -56.71% | 191B | |
| -0.52% | +4.45% | +32.12% | +98.51% | 186B | |
| Average | +0.53% | +3.75% | +17.91% | +65.47% | 360.59B | |
| Weighted average by Cap. | +0.24% | +3.10% | +35.04% | +61.98% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.03B 190M 165M 156M 142M 265M 18.19B 267M 1.87B 721M 9.25B 712M 696M 29.75B | 11.73B 369M 321M 303M 276M 516M 35.37B 519M 3.64B 1.4B 17.98B 1.38B 1.35B 57.86B |
| Net income | 3.66B 115M 100M 94.71M 86M 161M 11.04B 162M 1.13B 438M 5.61B 432M 422M 18.06B | 8.35B 262M 229M 216M 196M 368M 25.17B 369M 2.59B 998M 12.8B 986M 964M 41.18B |
| Net Debt | -8.42B -264M -231M -218M -198M -370M -25.37B -372M -2.61B -1.01B -12.9B -993M -971M -41.51B | -11.31B -355M -310M -293M -266M -498M -34.11B -500M -3.51B -1.35B -17.34B -1.34B -1.31B -55.8B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-18 | NT$85.80 | +3.50% | 6,225,688 |
| 26-09-17 | NT$82.90 | +1.59% | 2,593,148 |
| 26-09-16 | NT$81.60 | +2.13% | 4,166,800 |
| 26-09-15 | NT$79.90 | +0.76% | 4,142,059 |
| 26-09-14 | NT$79.30 | -0.25% | 2,862,127 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 6919 Stock
Select your edition
All financial news and data tailored to specific country editions
